Bill on seat belt admissibility heads to Governor
GlaxoSmithKline v. State of Louisiana
(U.S., filed August 8, 2018): Arguing that a State cannot invoke sovereign immunity to avoid being bound by a class settlement and, instead, bring a new lawsuit making identical claims when the State was expressly included in the class, received notice of the action and settlement, and did not opt out.
On December 18, 2018, the petition for cert was dismissed.
SCOTUS Determining Whether to Hear Appeal by Defendant
Writing for The Hill, ATRA President Tiger Joyce discusses the Biden administration’s plans to allow a settlement slush fund and issues the practice has caused at the state level.
ATRA President Tiger Joyce writes about issues with a landmark talc case in Missouri and how the U.S. Supreme Court can step in.
Trial lawyers’ spending on covid ads last year surpassed $260,000